Literature DB >> 33660615

Is REM sleep behavior disorder a friend or foe of obstructive sleep apnea? Clinical and etiological implications for neurodegeneration.

Yu Jin Jung1, Eungseok Oh2.   

Abstract

NONE: Rapid eye movement sleep behavior disorder (RBD) is a parasomnia characterized by loss of muscle atonia during rapid eye movement sleep, associated with complex motor enactment of dreams. Obstructive sleep apnea (OSA) is a relatively common sleep disorder characterized by repetitive episodes of upper airway obstruction while sleeping, which can result in hypoxemia and sleep fragmentation. Even though the nature of RBD and OSA is different, OSA may sometimes be accompanied by RBD symptoms. Accordingly, it is reasonable to distinguish these 2 sleep disorders in people with dream enactment behaviors. Although RBD and OSA share similar sleep phenomena, their association has yet to be elucidated. Herein we draw attention to various RBD-mimicking conditions, RBD combined with OSA, and the relationship between RBD and OSA. Furthermore, the clinical implications of OSA in neurodegeneration and the optimized management of RBD combined with OSA are also discussed in this review.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  REM sleep behavior disorder; dream enactment behavior; neurodegeneration; obstructive sleep apnea

Mesh:

Year:  2021        PMID: 33660615      PMCID: PMC8314663          DOI: 10.5664/jcsm.9144

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  77 in total

1.  The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies.

Authors:  Andrea Galbiati; Laura Verga; Enrico Giora; Marco Zucconi; Luigi Ferini-Strambi
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  EMG variance during polysomnography as an assessment for REM sleep behavior disorder.

Authors:  Joseph W Burns; Flavia B Consens; Roderick J Little; Karen J Angell; Sid Gilman; Ronald D Chervin
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

Review 3.  The Glymphatic System: A Beginner's Guide.

Authors:  Nadia Aalling Jessen; Anne Sofie Finmann Munk; Iben Lundgaard; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2015-05-07       Impact factor: 3.996

Review 4.  Brainstem and Autonomic Nervous System Dysfunction: A Neurosurgical Point of View.

Authors:  A Martín-Gallego; L González-García; A Carrasco-Brenes; M Segura-Fernández-Nogueras; A Delgado-Babiano; A Ros-Sanjuán; L Romero-Moreno; M Domínguez-Páez; M S Dawid-Milner; M A Arráez-Sánchez
Journal:  Acta Neurochir Suppl       Date:  2017

5.  Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series.

Authors:  Carolin Schaefer; Dieter Kunz; Frederik Bes
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

6.  Diagnosis and Management of Obstructive Sleep Apnea: A Review.

Authors:  Daniel J Gottlieb; Naresh M Punjabi
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

7.  A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder.

Authors:  Shirley Xin Li; Siu Ping Lam; Jihui Zhang; Mandy Wai Man Yu; Joey Wing Yin Chan; Yaping Liu; Venny Kwai Ho Lam; Crover Kwok Wah Ho; Junying Zhou; Yun Kwok Wing
Journal:  Sleep Med       Date:  2016-02-16       Impact factor: 3.492

8.  Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation.

Authors:  Aung K Htoo; Harly Greenberg; Shraddha Tongia; Guoqian Chen; Todd Henderson; David Wilson; Shu Fang Liu
Journal:  Sleep Breath       Date:  2006-03       Impact factor: 2.816

9.  Cognitive changes and sleep disordered breathing in elderly: differences in race.

Authors:  Mairav Cohen-Zion; Carl Stepnowsky; Sherella Johnson; Matt Marler; Joel E Dimsdale; Sonia Ancoli-Israel
Journal:  J Psychosom Res       Date:  2004-05       Impact factor: 3.006

Review 10.  Diagnostic biomarkers for Parkinson's disease at a glance: where are we?

Authors:  Ilaria Cova; Alberto Priori
Journal:  J Neural Transm (Vienna)       Date:  2018-08-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.